| $385M | ||
| $350M | ||
| $215M | ||
| $82M | ||
| $76M | ||
| $62M |
Buys | $81,908 | 9 | 100 |
Sells | $0 | 0 | 0 |
| Van Heel Kenneth | director | 2 | $30,813 | 0 | $0 | $30,813 |
| Baird Jennifer A | director | 3 | $17,976 | 0 | $0 | $17,976 |
| Neuman John | director | 1 | $14,396 | 0 | $0 | $14,396 |
| Chung Kevin | Chief Medical Officer | 2 | $13,625 | 0 | $0 | $13,625 |
| Messinger Michael | Chief Financial Officer | 1 | $5,098 | 0 | $0 | $5,098 |
SeaStar Medical Holding Corporation, a medical device company, focuses on providing novel solutions and services to treat hyperinflammation and cytokine storm in critically ill patients. The company is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. It is developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure with and without LVAD; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is based in Denver, Colorado.
Over the last 12 months, insiders at SeaStar Medical Holding Corporation have bought $81,908 and sold $0 worth of SeaStar Medical Holding Corporation stock.
On average, over the past 5 years, insiders at SeaStar Medical Holding Corporation have bought $75,190 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Van Heel Kenneth (director) — $30,813. Baird Jennifer A (director) — $17,976. Neuman John (director) — $14,396.
The last purchase of 4,200 shares for transaction amount of $987 was made by Baird Jennifer A (director) on 2025‑12‑19.
| 2025-12-19 | Baird Jennifer A | director | 4,200 0.0147% | $0.24 | $987 | +0.41% | ||
| 2025-12-09 | Messinger Michael | Chief Financial Officer | 14,500 0.0513% | $0.35 | $5,098 | -30.34% | ||
| 2025-08-27 | Van Heel Kenneth | director | 10,000 0.0362% | $0.86 | $8,565 | -62.50% | ||
| 2025-08-26 | Van Heel Kenneth | director | 25,000 0.0996% | $0.89 | $22,248 | -64.46% | ||
| 2025-08-22 | Chung Kevin | Chief Medical Officer | 10,000 0.0358% | $0.80 | $8,000 | -59.00% | ||
| 2025-06-30 | Baird Jennifer A | director | 10,000 0.0608% | $0.42 | $4,174 | +25.00% | ||
| 2025-06-24 | Neuman John | director | 40,000 0.3573% | $0.36 | $14,396 | +39.58% | ||
| 2025-05-20 | Chung Kevin | Chief Medical Officer | 4,500 0.0414% | $1.25 | $5,625 | -56.59% | ||
| 2025-05-20 | Baird Jennifer A | director | 10,000 0.0944% | $1.28 | $12,815 | -56.59% | ||
| 2024-12-11 | Neuman John | director | 10,000 0.2126% | $2.04 | $20,405 | -44.26% | ||
| 2024-11-18 | Chung Kevin | Chief Medical Officer | 4,250 0.0842% | $1.99 | $8,458 | -44.89% | ||
| 2024-09-30 | Chung Kevin | Chief Medical Officer | 1,000 0.025% | $4.26 | $4,258 | -66.08% | ||
| 2024-08-15 | Neuman John | director | 10,000 0.1724% | $5.24 | $52,396 | -70.23% | ||
| 2024-06-17 | Neuman John | director | 10,000 0.3451% | $4.35 | $43,521 | -44.49% | ||
| 2024-06-14 | Neuman John | director | 10,000 0.2927% | $3.69 | $36,905 | -43.38% | ||
| 2023-11-22 | Van Heel Kenneth | director | 100,000 0.5274% | $0.40 | $40,000 | -2.62% | ||
| 2023-05-30 | Chung Kevin | Chief Medical Officer | 12,543 0.17% | $0.47 | $5,953 | -1.66% | ||
| 2022-04-05 | Chung Kevin | Chief Medical Officer | 3,760 0.1986% | $1.85 | $6,956 | +4209.11% |
| Neuman John | director | 80000 2.8689% | $215,200.00 | 5 | 0 | <0.0001% |
| Chung Kevin | Chief Medical Officer | 58184 2.0866% | $156,514.96 | 6 | 0 | <0.0001% |
| Van Heel Kenneth | director | 49400 1.7716% | $132,886.00 | 3 | 0 | <0.0001% |
| Baird Jennifer A | director | 36200 1.2982% | $97,378.00 | 3 | 0 | |
| Messinger Michael | Chief Financial Officer | 17500 0.6276% | $47,075.00 | 1 | 0 |
$13,664,154 | 40 | -70.35% | $6.72M | |
$1,029,337 | 36 | -28.38% | $7.5M | |
$29,635,355 | 27 | 9.05% | $5.24M | |
$63,749,694 | 24 | -12.24% | $7.95M | |
$37,200,153 | 21 | -47.67% | $8.18M | |
$1,039,491 | 21 | -11.76% | $7.36M | |
$742,412 | 14 | -50.36% | $6.09M | |
$188,726 | 11 | -28.87% | $7.79M | |
$405,510 | 11 | -46.23% | $6.62M | |
$105,917 | 11 | -28.06% | $8.61M | |
$120,379 | 10 | -24.48% | $8.02M | |
SeaStar Medical Holding Corporation (ICU) | $211,895 | 8 | -39.70% | $7.5M |
$8,971,546 | 8 | 6.18% | $5.6M | |
$159,974 | 7 | -18.60% | $6.35M | |
$1,184,658 | 4 | -22.17% | $8.14M | |
$157,740 | 3 | 153.95% | $8.9M | |
$1,057,000 | 3 | 5.27% | $7.23M | |
$28,395 | 3 | 3.48% | $8.39M | |
$31,190 | 2 | -14.18% | $6.9M |
| Increased Positions | 8 | +25.81% | 21,651 | +19.79% |
| Decreased Positions | 10 | -32.26% | 51,097 | -46.7% |
| New Positions | <1 | New | 12,695 | New |
| Sold Out Positions | 9 | Sold Out | 51,037 | Sold Out |
| Total Postitions | 29 | -6.45% | 79,958 | -26.91% |
| Vanguard Group Inc | $99.00 | <0.01% | 377,377 | +319,879 | +556.33% | 2025-09-30 |
| Geode Capital Management, Llc | $68.00 | <0.01% | 258,922 | +190,094 | +276.19% | 2025-09-30 |
| Millennium Management Llc | $47.00 | <0.01% | 179,673 | +179,673 | New | 2025-09-30 |
| Trinity Financial Advisors Llc | $13.00 | <0.01% | 50,000 | +35,000 | +233.33% | 2025-09-30 |
| Xtx Topco Ltd | $13.00 | <0.01% | 48,558 | -12,425 | -20.38% | 2025-09-30 |
| Dynamic Advisor Solutions Llc | $8.00 | <0.01% | 29,278 | +29,278 | New | 2025-09-30 |
| Toronto Dominion Bank | $7.00 | <0.01% | 25,000 | +25,000 | New | 2025-09-30 |
| Goldman Sachs Group Inc | $5.00 | <0.01% | 18,986 | +6,562 | +52.82% | 2025-09-30 |
| Raymond James Financial Inc | $5.00 | <0.01% | 17,714 | -19,547 | -52.46% | 2025-09-30 |
| Tyche Wealth Partners Llc | $5.00 | <0.01% | 17,700 | -20,000 | -53.05% | 2025-09-30 |